Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

NCT02138838 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
55
Enrollment
INDUSTRY
Sponsor class

Stopped Amgen decided to terminate the study early to be able to meet US regulatory timelines fo filing. Subjects in treatment were rolled over to the 20140159 study.

Conditions

Interventions

Sponsor

Amgen